Lung transplantation for suppurative diseases
Autor: | Rhob Teixeira, Fabio Biscegli Jatene, J.E. Afonso, L Turaça, L.G. Abdalla, DS Ferronatto, Liliam Fernandes, P M Pego Fernandes, Marcos Naoyuki Samano, Silvia Vidal Campos |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Bronchiectasis business.industry Incidence (epidemiology) medicine.medical_treatment General Medicine medicine.disease Pulmonary hypertension Gastroenterology law.invention Surgery Cardiac surgery Cardiothoracic surgery law Internal medicine medicine Cardiopulmonary bypass Lung transplantation Oral Presentation Cardiology and Cardiovascular Medicine business Survival rate |
Zdroj: | Journal of Cardiothoracic Surgery |
ISSN: | 1749-8090 |
Popis: | Of 150 LTx performed, 59 patients (39.3%) had suppurative diseases, 29 (19.3%) were non-CF and 30 (20%) had CF. In non-CF group, mean age was 40.2 ± 12.6 years, male predominance (58.3%) and all bilateral. Pulmonary hypertension was present in 50%, but cardiopulmonary bypass (CPB) used n 13.8%. None case of PGD3 was seen in this group. CF patients were younger (27.4 + 9.2 years), 53% males and almost all bilateral (97%). 30% had pulmonary hypertension, CPB used in 10% and 10% developed PGD3 . There were no difference in ventilation time, ICU and hospital stay. The survival rate at 1 and 5 years in CF was 92% and 77% and in non-CF was 84% and 75%. There was no difference according survival but these both groups showed better survival than other underlying diseases (p < 0.001). Conclusions Suppurative diseases are important source of patients for LTx in our program. The incidence of non-CF bronchiectasis is especially high corresponding to the forth indication. The survival rates of these both groups are excellent and comparable to other reports. |
Databáze: | OpenAIRE |
Externí odkaz: |